TapewireFind a company

person · Reporting owner

Haas Kevin Richard

Disclosed activity across 2 companies

Tapewire entity
52522
SEC CIK
0001843872

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
VERACYTE, INC.VCYT · Entity 2018Chief Dev and Tech OfficerApril 10, 2026April 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

VERACYTE, INC.

Report date April 10, 2026 · Filed April 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,221 Reported balance After 2026-04-10 transaction · row 1
1 source row

Row 1 · 2026-04-10 · Grant · Acquired 44,221 · Balance 44,221

F1: Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

MYRIAD GENETICS INC

Report date March 13, 2026 · Filed March 16, 2026

Section 16 reporting ended · disclosed 2026-03-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect180,022 Ending reported balance After 2026-03-15 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2026-03-13 · Tax withholding · Disposed 6,412 · Balance 195,920

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Row 2 · 2026-03-14 · Tax withholding · Disposed 4,161 · Balance 191,759

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Row 3 · 2026-03-15 · Tax withholding · Disposed 3,355 · Balance 188,404

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Row 4 · 2026-03-15 · Tax withholding · Disposed 8,382 · Balance 180,022

F2: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

F2: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 10, 2026 Filed Apr 14, 2026 21:03 UTC VERACYTE, INC. VCYT · Entity 2018 GrantCommon Stock 44,221 $0.00 $0.00
Disclosure

SEC source: 0001843872-26-000011 · wk-form4_1776200598.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Dev and Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,221

F1 · kind: Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Read SEC document
March 15, 2026 Filed Mar 16, 2026 21:58 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 8,382 $4.66 $39,060.12
Disclosure

SEC source: 0001843872-26-000005 · wk-form4_1773698278.xml · nonDerivative · entry 4

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,022

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026.

Read SEC document
March 15, 2026 Filed Mar 16, 2026 21:58 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 3,355 $4.66 $15,634.30
Disclosure

SEC source: 0001843872-26-000005 · wk-form4_1773698278.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,404

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
March 14, 2026 Filed Mar 16, 2026 21:58 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 4,161 $4.66 $19,390.26
Disclosure

SEC source: 0001843872-26-000005 · wk-form4_1773698278.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,759

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 21:58 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 6,412 $4.66 $29,879.92
Disclosure

SEC source: 0001843872-26-000005 · wk-form4_1773698278.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,920

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
February 02, 2026 Filed Feb 3, 2026 22:29 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 23,697 $0.00 $0.00
Disclosure

SEC source: 0001843872-26-000003 · wk-form4_1770157795.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,332

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:17 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,724 $9.98 $17,205.52
Disclosure

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 4

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,635

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

Read SEC document
March 24, 2025 Filed Mar 25, 2025 20:17 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,177 $9.98 $11,746.46
Disclosure

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,359

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

Read SEC document
March 22, 2025 Filed Mar 25, 2025 20:17 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 4,493 $10.01 $44,974.93
Disclosure

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,536

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

Read SEC document
March 22, 2025 Filed Mar 25, 2025 20:17 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,694 $10.01 $16,956.94
Disclosure

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,029

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

Read SEC document
March 15, 2025 Filed Mar 17, 2025 20:20 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 3,335 $10.07 $33,583.45
Disclosure

SEC source: 0001628280-25-013151 · wk-form4_1742242801.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,723

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025.

Read SEC document
March 14, 2025 Filed Mar 17, 2025 20:20 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 4,390 $10.07 $44,207.30
Disclosure

SEC source: 0001628280-25-013151 · wk-form4_1742242801.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,058

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025.

Read SEC document
March 13, 2025 Filed Mar 17, 2025 20:20 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 54,124 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-013151 · wk-form4_1742242801.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,448

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 21:21 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,016 $11.74 $11,927.84
Disclosure

SEC source: 0001843872-25-000002 · wk-form4_1740604855.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,566

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2025.

Read SEC document
February 07, 2025 Filed Mar 5, 2025 00:31 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 12,758 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-010138 · wk-form4_1741134694.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,324

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.

Read SEC document
October 09, 2024 Filed Oct 10, 2024 20:31 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 2,515 $24.37 $61,290.55
Disclosure

SEC source: 0001843872-24-000004 · wk-form4_1728592265.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,582

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024.

Read SEC document
March 24, 2024 Filed Mar 25, 2024 20:31 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,718 $22.24 $38,208.32
Disclosure

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,097

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

Read SEC document
March 24, 2024 Filed Mar 25, 2024 20:31 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,172 $22.24 $26,065.28
Disclosure

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,815

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

Read SEC document
March 22, 2024 Filed Mar 25, 2024 20:31 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,685 $22.24 $37,474.40
Disclosure

SEC source: 0001628280-24-012917 · wk-form4_1711398681.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,987

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

Read SEC document
March 15, 2024 Filed Mar 18, 2024 20:45 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 3,306 $21.16 $69,954.96
Disclosure

SEC source: 0001628280-24-011685 · wk-form4_1710794740.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,672

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 20:45 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 35,178 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-011685 · wk-form4_1710794740.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,978

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 25, 2024 Filed Feb 26, 2024 21:12 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 881 $22.72 $20,016.32
Disclosure

SEC source: 0001843872-24-000002 · wk-form4_1708981929.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,800

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 23, 2024.

Read SEC document
October 09, 2023 Filed Oct 10, 2023 20:17 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,710 $15.01 $25,667.10
Disclosure

SEC source: 0001843872-23-000006 · wk-form4_1696969050.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,681

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023.

Read SEC document
September 26, 2023 Filed Sep 27, 2023 20:21 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 858 $15.99 $13,719.42
Disclosure

SEC source: 0001843872-23-000004 · wk-form4_1695846072.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,391

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023.

Read SEC document
March 24, 2023 Filed Mar 27, 2023 20:28 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,674 $23.72 $39,707.28
Disclosure

SEC source: 0001628280-23-009263 · wf-form4_167994888071580.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,249

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

Read SEC document
March 24, 2023 Filed Mar 27, 2023 20:28 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,142 $23.72 $27,088.24
Disclosure

SEC source: 0001628280-23-009263 · wf-form4_167994888071580.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,923

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

Read SEC document
March 22, 2023 Filed Mar 23, 2023 20:28 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,677 $22.91 $38,420.07
Disclosure

SEC source: 0001628280-23-009050 · wf-form4_167960331971225.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,065

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:29 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 28,459 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-008319 · wf-form4_167899858730951.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,742

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 25, 2023 Filed Feb 27, 2023 21:08 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,012 $18.54 $18,762.48
Disclosure

SEC source: 0001843872-23-000001 · wf-form4_167753204919533.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,283

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 24, 2023.

Read SEC document
October 09, 2022 Filed Oct 11, 2022 20:33 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,721 $19.62 $33,766.02
Disclosure

SEC source: 0001628280-22-026249 · wf-form4_166552041395150.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,295

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022.

Read SEC document
September 26, 2022 Filed Sep 27, 2022 20:32 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 862 $18.41 $15,869.42
Disclosure

SEC source: 0001628280-22-025567 · wf-form4_166431075031059.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,016

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022.

Read SEC document
September 25, 2022 Filed Sep 27, 2022 20:32 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 346 $18.69 $6,466.74
Disclosure

SEC source: 0001628280-22-025567 · wf-form4_166431075031059.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,878

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022.

Read SEC document
March 24, 2022 Filed Mar 25, 2022 21:08 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,689 $25.32 $42,765.48
Disclosure

SEC source: 0001843872-22-000008 · edgardoc.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,224

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

Read SEC document
March 24, 2022 Filed Mar 25, 2022 21:08 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,153 $25.32 $29,193.96
Disclosure

SEC source: 0001843872-22-000008 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,913

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022.

Read SEC document
March 22, 2022 Filed Mar 23, 2022 20:59 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 19,238 $0.00 $0.00
Disclosure

SEC source: 0001843872-22-000006 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,066

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 22:02 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 865 $24.69 $21,356.85
Disclosure

SEC source: 0001843872-22-000004 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,828

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 22:19 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 19,520 $0.00 $0.00
Disclosure

SEC source: 0001843872-22-000002 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,693

F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025.

Read SEC document
October 09, 2021 Filed Oct 12, 2021 20:39 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,729 $30.88 $53,391.52
Disclosure

SEC source: 0001843872-21-000015 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,173

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.

Read SEC document
September 26, 2021 Filed Sep 27, 2021 23:54 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 865 $33.31 $28,813.15
Disclosure

SEC source: 0001843872-21-000013 · edgardoc.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,902

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.

Read SEC document
September 25, 2021 Filed Sep 27, 2021 23:54 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 346 $33.31 $11,525.26
Disclosure

SEC source: 0001843872-21-000013 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,767

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.

Read SEC document
May 28, 2021 Filed Jun 3, 2021 22:42 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 344 $15.86 $5,456.18
Disclosure

SEC source: 0001843872-21-000011 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,113

F1 · kind: These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 24, 2021 Filed Mar 26, 2021 20:33 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 13,326 $0.00 $0.00
Disclosure

SEC source: 0001843872-21-000009 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,769

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:38 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001843872-21-000006 · edgardoc.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · SVP Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,443

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2022, 25% on February 18, 2023, 25% on February 18, 2024, and 25% on February 18, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.